Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. Its programs in hematology and genetic disease portfolio include Ristoglogene autogetemcel, a patient-specific, autologous...
2 insider purchases on record · latest filing 2012-08-16.
Insiders have also filed 303 sale transactions at BEAM.